CWAN vs SLAB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CWAN exhibits a critical disconnect between explosive top-line growth and fundamental financial health, evidenced by a weak Piotroski F-Score of 2/9. While revenue growth is an impressive 72% YoY, the valuation is severely stretched with a PEG ratio of 10.15 and a Price/Sales ratio of 9.83. This fundamental weakness is compounded by aggressive insider selling from the CEO, CFO, and CTO, and a bearish technical trend. Despite a consistent track record of earnings beats, the lack of GAAP profitability and poor deterministic health scores suggest the stock is significantly overvalued.
SLAB exhibits a severe disconnect between its market price and fundamental operational health, highlighted by a weak Piotroski F-Score of 2/9. While the company maintains an exceptionally clean balance sheet with minimal debt and high liquidity, it remains unprofitable with negative net and operating margins. The stock has experienced a massive 135% price surge over the last year, pushing it to its 52-week high despite a high PEG ratio of 3.12 and bearish insider selling. The current valuation appears speculative, relying on EPS recovery rather than established financial stability.
Compare Another Pair
Related Comparisons
CWAN vs SLAB: Head-to-Head Comparison
This page compares Clearwater Analytics Holdings, Inc. (CWAN) and Silicon Laboratories Inc. (SLAB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.